CAR-T 细胞治疗前基于苯达莫司汀的淋巴细胞清除:一项系统综述 Bendamustine-based lymphodepletion prior to CAR T-cell therapy: a systematic review. PubMed 2026/06/22 发表Bone Marrow TransplantQ1 · IF 5.1(JCR 2025) 靶点:CD19靶点:CD30靶点:BCMA技术:CAR-T技术:造血干细胞非霍奇金淋巴瘤霍奇金淋巴瘤多发性骨髓瘤
套细胞淋巴瘤转化为 CD19 阴性经典型霍奇金淋巴瘤:CD19 CAR-T 细胞治疗逃逸的新机制 Mantle cell lymphoma transformation to CD19-negative classic Hodgkin lymphoma as a novel mechanism of escape from CD19 chimeric antigen receptor T cel PubMed 2025/12/10 发表J HematopQ4 · IF 1(JCR 2025) 靶点:CD19靶点:CD30技术:CAR-T套细胞淋巴瘤霍奇金淋巴瘤地区:美国
成人 CD30 CAR-T 细胞治疗后的感染并发症 Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults. PubMed 2025/09/18 发表Open Forum Infect DisQ2 · IF 3.8(JCR 2025) 人群:成人靶点:CD19靶点:CD30技术:CAR-T外周T细胞淋巴瘤霍奇金淋巴瘤
SOHO 最新进展与后续问题 | 原发性纵隔 B 细胞淋巴瘤治疗的最新进展 SOHO State of the Art Updates and Next Questions | Latest Advances in the Management of Primary Mediastinal B-Cell Lymphoma. PubMed 2025/02/27 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 人群:儿童人群:成人靶点:CD19靶点:CD30技术:CAR-T技术:双特异性抗体
淋巴瘤的 CAR-T 细胞治疗:新场景与未来方向 Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. PubMed 2023/12/21 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T大B细胞淋巴瘤滤泡性淋巴瘤霍奇金淋巴瘤
经典型霍奇金淋巴瘤的 CAR-T 细胞治疗 CAR-T Cell Therapy for Classical Hodgkin Lymphoma. PubMed 2023/11/16 发表HemasphereQ1 · IF 11.3(JCR 2025) 靶点:CD19靶点:CD20靶点:CD30技术:CAR-T霍奇金淋巴瘤地区:欧洲
霍奇金淋巴瘤的遗传学病变与靶向治疗 Genetic lesions and targeted therapy in Hodgkin lymphoma. PubMed 2023/01/12 发表Ther Adv HematolQ2 · IF 2.8(JCR 2025) 靶点:CD19靶点:CD22靶点:CD30技术:CAR-T弥漫大B细胞淋巴瘤霍奇金淋巴瘤
儿童和青少年癌症患者 CAR-T 细胞药物研发儿科战略论坛:ACCELERATE 与欧洲药品管理局合作、美国食品药品监督管理局参与 Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE i PubMed 2021/11/25 发表Eur J CancerQ1 · IF 7.9(JCR 2025) 人群:儿童人群:成人靶点:CD19靶点:CD20靶点:CD22技术:CAR-T技术:NK 细胞技术:造血干细胞
霍奇金淋巴瘤的过继性 T 细胞治疗 Adoptive T-cell therapy for Hodgkin lymphoma. PubMed 2021/10/26 发表Blood AdvQ1 · IF 7.7(JCR 2025) 靶点:CD19靶点:CD30靶点:CD123技术:CAR-T非霍奇金淋巴瘤霍奇金淋巴瘤